Ambu A/S
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMBFF research report →
Companywww.ambu.com
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
- CEO
- Britt Meelby Jensen
- IPO
- 2017
- Employees
- 5,000
- HQ
- Ballerup, DK
Price Chart
Valuation
- Market Cap
- $2.62B
- P/E
- 38.20
- P/S
- 2.98
- P/B
- 2.99
- EV/EBITDA
- 17.40
- Div Yield
- 0.60%
Profitability
- Gross Margin
- 55.82%
- Op Margin
- 10.71%
- Net Margin
- 7.81%
- ROE
- 7.92%
- ROIC
- 7.56%
Growth & Income
- Revenue
- $6.03B · 11.78%
- Net Income
- $607.84M · 158.66%
- EPS
- $2.28 · 159.09%
- Op Income
- $782.51M
- FCF YoY
- 28.38%
Performance & Tape
- 52W High
- $15.81
- 52W Low
- $9.90
- 50D MA
- $13.57
- 200D MA
- $13.97
- Beta
- 1.26
- Avg Volume
- 3
Get TickerSpark's AI analysis on AMBFF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AMBFF Coverage
We haven't published any research on AMBFF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AMBFF Report →